Merck Aktie
109,30
EUR
-0,75
EUR
-0,68
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 155,00 EUR | +41,29% | 03.06.2025 | |
| Deutsche Bank AG | 174,00 EUR | +58,61% | 30.05.2025 | |
| Bernstein Research | 147,00 EUR | +34,00% | 27.05.2025 | |
| Goldman Sachs Group Inc. | 165,00 EUR | +50,41% | 16.05.2025 | |
| UBS AG | 180,00 EUR | +64,08% | 16.05.2025 | |
| DZ BANK | - | - | 15.05.2025 | |
| Barclays Capital | 160,00 EUR | +45,85% | 12.05.2025 | |
| Jefferies & Company Inc. | 180,00 EUR | +64,08% | 14.11.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | +31,09% |
| BASF | 4 | 5 | 2 | 49,22 EUR | +18,32% |
| Bayer | 2 | 7 | 0 | 26,00 EUR | -1,31% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 8 | 1 | 2 | 143,10 EUR | +32,93% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | +28,98% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 1 | 6 | 1 | 16,30 GBP | +16,18% |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 3 | 5 | 2 | 368,33 EUR | +2,21% |
| LANXESS AG | 3 | 3 | 3 | 26,56 EUR | +10,21% |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 165,86 EUR | +51,19% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +4,91% |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +21,39% |
| Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +9,92% |
| Reckitt Benckiser Plc | 4 | 6 | 0 | 58,22 GBP | +15,29% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 116,12 EUR | +39,37% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 48,66 GBP | +6,29% |
| WACKER CHEMIE AG | 5 | 3 | 0 | 80,43 EUR | +31,42% |